Massive Increase in Accidental Overdoses from Weight-Loss Drugs, Reports U.S. Poison Centers | HerDailyMail

Massive Increase in Accidental Overdoses from Weight-Loss Drugs, Reports U.S. Poison Centers

MA

Magret

Thumbnail

“Imagine a medicine meant to improve your health, turning into a nationwide emergency. This is the reality of semaglutide, a drug facing an alarming misuse crisis.”

Across America, poison control centers are sounding the alarm. A staggering 1,500% increase in calls since 2019, all pointing to one culprit: semaglutide. A drug approved for diabetes and weight loss now finds itself in the center of a health scare.

[From the East Coast to the West, people are experiencing severe symptoms — vomiting, nausea, abdominal pain. While most cases are resolved with medical intervention, the sheer volume of these incidents is causing nationwide concern.

Dr. Kait Brown reveals a worrying pattern. The majority of these calls? Simple dosage errors. Double doses, wrong doses — mistakes that are easy to make but can have serious consequences.

Adding to the drug’s popularity, celebrities like Sharon Osbourne and Robbie Williams have publicly shared their use of semaglutide, potentially influencing public perception and use.

Dr. Joseph Lambson’s in-depth study exposes the dangers of compounded semaglutide. In his report, cases of patients taking up to ten times the standard dose shed light on the risks of these less-regulated formulations.

Lambson points to a critical issue: compounded semaglutide lacks the safety features of pre-filled pens, leading to a rise in overdosing incidents.

But even the safer pre-filled pens aren’t without issues. Julie Weber shares alarming stories of misuse leading to potentially dangerous overdoses.

In response to the crisis, Novo Nordisk emphasizes its commitment to safety and responsible usage of semaglutide.

Lambson’s report underlines the urgent need for better patient education and oversight. It’s a call for action to ensure safety in medication administration.

“Stay on top of vital health news – subscribe to HERDAILYMAIL’s newsletter for the latest updates on this unfolding story.”

“In the battle against diabetes and obesity, semaglutide emerges as both a solution and a challenge. The path forward? Awareness, education, and cautious use.”

MA

About Magret

...